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Background. We developed a model-based control system using end-tidal carbon dioxide
fraction (FE¢CO2) to adjust a ventilator during clinical anaesthesia.
Methods. We studied 16 ASA I±II patients (mean age 38 (range 20±59) yr; weight 67 (54±87)
kg) during i.v. anaesthesia for elective surgery. After periods of normal ventilation the patients
were either hyper- or hypoventilated to assess precision and dynamic behaviour of the control
system. These data were compared with a previous group where a fuzzy-logic controller had
been used. Responses to different clinical events (invalid carbon dioxide measurement, limb
tourniquet release, tube cuff leak, exhaustion of carbon dioxide absorbent, simulation of
pulmonary embolism) were also noted.
Results. The model-based controller correctly maintained the setpoint. No signi®cant
difference was found for the static performance between the two controllers. The dynamic
response of the model-based controller was more rapid (P<0.05). The mean rise time after a
setpoint increase of 1 vol% was 313 (SD 90) s and 142 (17) s for fuzzy-logic and model-based
control, respectively, and after a 1 vol% decrease was 355 (127) s and 177 (36) s, respectively.
The new model-based controller had a consistent response to clinical artefacts.
Conclusion. A model-based FE¢CO2 controller can be used in a clinical setting. It reacts
appropriately to artefacts, and has a better dynamic response to setpoint changes than a
previously described fuzzy-logic controller.
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During anaesthesia, carbon dioxide production varies. Thus,
the minute volume has to be adjusted to maintain end-tidal
carbon dioxide fraction (FE¢CO2) within acceptable clinical
limits. Several options can be chosen to adjust the venti-
lation settings, depending on the patient's disease and the
surgery. An automatic control system might relieve the
anaesthetist from this continuous control work. New
technologies and better modelling methods have increased
interest in automatic systems in anaesthesiology.1 In 1996,
we compared the performance of fuzzy-logic control of
FE¢CO2 with manual ventilation control and found that
fuzzy-logic feedback control was reliable.2 Fuzzy-logic
systems use a rule-based method to control a process
without an explicit mathematical model of the input±output
relationship. An important disadvantage of fuzzy-logic
control, however, is its limited transparency. In particular,
the steps leading to correction of the error with respect to the
setpoint are not easily understood because of the complex
interaction of many rules. Optimal adaptation to individual
needs is therefore dif®cult. Fuzzy-logic rules and their
interactions are developed empirically and depend on the
expertise of those who develop them. In contrast, model-
based control uses scienti®cally established mathematical
models derived from known physiological processes. This
makes the controller more transparent so that a priori
information (not available to the fuzzy-logic controller) can
improve dynamic performance and optimize individual
responses.
British Journal of Anaesthesia 92 (6): 800±7 (2004)
DOI: 10.1093/bja/aeh145 Advance Access publication April 19, 2004
Ó The Board of Management and Trustees of the British Journal of Anaesthesia 2004
We designed a new model-based controller for mechan-
ical ventilation, applied it clinically and studied the response
to artefacts. We assessed setpoint precision and dynamic
behaviour and compared this with a fuzzy-logic controller
presented by SchaÈublin and colleagues.2 We expected the
new device to be as stable and have a better dynamic
response.
Methods
After local ethical approval and with the patients' written
informed consent, 16 ASA physical status class I or II
patients were studied. They were aged 18±60 yr, BMI was
15±30 and they were scheduled for elective general
anaesthesia under mechanical ventilation. We excluded
patients with chronic obstructive pulmonary disease and
patients undergoing emergency, pulmonary or intracranial
surgery, and operations lasting less than 2 h.
The patients were given omeprazole 40 mg orally the
evening before surgery and premedicated with midazolam
7.5 mg orally 1±2 h before surgery. Anaesthesia was
induced with propofol 2 mg kg±1and fentanyl 0.3 mg kg±1
i.v. followed by a continuous infusion of propofol and
remifentanil according to clinical needs. A dose of
mivacurium 0.3 mg kg±1 was given using an Asena-GHÔ
pump and the trachea was intubated. Oesophageal tempera-
ture was measured and kept above 35 °C using a forced air
warmer blanket. Standard measures during the study
included: invasive continuous and non-invasive intermittent
systolic, diastolic and mean arterial pressure, continuous
ECG, heart rate, FE¢CO2, ventilatory frequency (f), tidal
volume (VT), minute volume (MV), transcutaneous periph-
eral oxygen saturation, peak (PPeak) and plateau airway
pressure, inspired oxygen fraction, bispectral index and
neuromuscular blockade monitoring using electromyogra-
phy.
The FE¢CO2 was measured at the mouthpiece by side-
stream infrared spectrometry (DraÈger Medical AG, LuÈbeck,
Germany), calibrated according to the manufacturer's
instructions. This gave an input signal for the automatic
ventilation controller. Normoventilation was de®ned as
FE¢CO2=4.5% (35 mm Hg), hyperventilation as FE¢CO2=3.5%
(28 mm Hg) and hypoventilation as FE¢CO2=5.5% (42 mm
Hg). All patients were initially normoventilated. After
reaching the target FE¢CO2 and having maintained a stable
measurement period of at least 15 min, the setpoint was
randomly changed to either hyperventilation or hypoventi-
lation (1 vol% (7 mm Hg) setpoint change respectively). To
assess the dynamic performance of the controller, the
setpoint was changed by 2 vol% and 1 vol% steps until the
end of the operation, maintaining a setpoint for at least
15 min. Manual control of ventilation was re-established for
the end of anaesthesia. All monitoring data were digitized
every 5 s and stored on a hard disk.
Mathematical model and controller design
The physiological model was derived from Chiari and
colleagues.3 They presented a comprehensive model of
oxygen and carbon dioxide exchange, transport and storage
in the adult human that gave realistic responses under
different physiological conditions. The model had three
compartments (lung, brain and body tissue) with corres-
ponding mass-balance descriptions including compartment
volume, gas exchange and metabolic production. For the
controller design, the model was simpli®ed by assuming
constant cardiac output and constant oxygen saturation in
arterial and venous blood, so that carbon dioxide dis-
sociation curves were not affected by oxygen saturation.4
This gave a model that was considered suf®ciently descrip-
tive for closed-loop control purposes. A simpli®ed sche-
matic structure of the controller is shown in Figure 1.
Based on the physiological model, the controller included
an observer system to predict the end-tidal fraction as well
as the non-measurable compartmental concentrations. In
case the measured input signal was transiently invalid
because of sensor or clinical artefacts, the controller would
switch to the predicted FE¢CO2 (FE¢CO2pred) from the
physiological model instead of the measured FE¢CO2, to
increase the safety and applicability of the controller in
routine practice.
The desired MV was calculated by the controller every
5 s. Algorithm J was developed to translate this value into
appropriate values of f and VT for the ventilation system. An
upper constraint on Ppeak and desired settings for ventilatory
frequency fD and tidal volume VTD was set by the
anaesthetist to account for different patient features. When
Ppeak was reached, f was automatically increased, thus VT
decreased and Ppeak was reduced.
Observer-based feedback systems are generally less
sensitive to variation and therefore the controller could be
tuned more aggressively than standard proportional-inte-
gral-derivative controllers. By adding an integral action (kI),
steady-state errors could be minimized. The controller was
set up on a real-time control platform interfaced with a
modi®ed Cicero anaesthesia workplace (DraÈger Medical
AG, LuÈbeck, Germany).
Performance analysis and statistics
Controller performance was assessed by comparing the
measured FE¢CO2 values (the controlled variable Cm) and the
preset FE¢CO2 reference values (Cr) and calculating eFE¢CO2
as the difference between the FE¢CO2 reference value and the
measured FE¢CO2 value. To assess the setpoint precision, the
variables listed below were calculated for each patient for
all setpoint values of the ventilation pattern (normo-, hyper-
and hypoventilation) for the period of 10 min before
changing to the next setpoint. The ®rst two variables were
de®ned as in the previous group with fuzzy-logic control,
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whereas variables 3±7 were calculated for the model-based
control group only:
(1) MD, the mean deviation from setpoint (MD=mean
eFE¢CO2) as an indicator of the bias of the control.
(2) MDS, the standard deviation of eFE¢CO2 as an indicator
of the stability and range of deviation of the control.
(3) MAD, the mean absolute deviation from setpoint
resulting in Equation 1 for subject i as an indicator of
inaccuracy of the control, where Cmij and Crij represent the
jth measured and reference value for the ith subject,
respectively.
MADi  1
Ni
XNi
j1
Cmij ÿ Crij 1
Additional measures as proposed by Varvel and colleagues5
for the evaluation of the prediction performance of
computer-controlled infusion pumps and also used to assess
setpoint precision of feedback systems,6 7 were calculated.
(4) MDAPE, the median absolute performance error,
an indicator of precision or inaccuracy of the control in
subject i.
MDAPEi  median
PEij; j  1;::::;Ni	 2
where PEij is the performance error calculated as the
weighted difference between measured and reference values
(Equation 3) and Ni is the number of performance errors in
the ith subject.
PEij  Cmij ÿ Crij
Crij
 100 3
(5) MDPE, the median performance error, indicator of bias
of the control in subject i, including the signs of the errors
(Equation 4).
MDPEi  median

PEij; j  1;::::;Ni
	 4
(6) The wobble is the measure of the variability of the
performance errors in subject i (Equation 5).
wobblei  median
PEij ÿMDPEi; j  1;::::;Ni	 5
(7) The divergence measures the time-related trend of the
measured effects in relation to the targeted values.
As indicators of dynamic performance, we measured rise
time (time required to move from 10% to 90% of steady
state of the desired change) and overshoot (the absolute
maximum value achieved, expressed as absolute value
above or below the steady-state value after a step change of
the setpoint).2 8 9
SchaÈublin and colleagues2 studied 20 male and 10 female
ASA class I±III patients (mean age 47 (range 12±84) yr;
weight 67 (41±93) kg), during general anaesthesia for
elective surgery. Anaesthetic management except venti-
lation was according to usual practice. They imposed two
step changes from a target FE¢CO2 of 4.5 to 5.5%, each step
lasting at least 20 min. The sequence of the two steps done
manually and by the fuzzy-logic controller was chosen
randomly. They measured static performance, using indi-
cators 1 and 2 above, for each individual in the last 10 min
of each step. Dynamic performance was assessed as above.
The patients in the current clinical trial were compared
with this historic control group using Student's t-test.
P<0.05 was considered signi®cant using a power of 0.8.
Results
Out of the 16 enrolled patients, one patient was excluded
because copious lung secretions were a problem in the
lateral position for hip surgery. The model-based group and
Fig 1 Simpli®ed structure of the controller with patient, model (observer system), state feedback control vector (k), additional integral part (kI), minute
volume (MV), peak airway pressure (Ppeak), measured FE¢CO2, predicted FE¢CO2 (FE¢CO2pred) and setpoint reference FE¢CO2 (FE¢CO2ref), algorithm block
(J) with additional inputs from the anaesthetist for desired respiratory frequency (fD) and tidal volume (VTD).
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fuzzy-logic group are compared in Table 1. A sample data
trace is shown in Figure 2.
The controller kept Ppeak below the prede®ned limits
throughout the trial for both steady-state and dynamic
phases.
Setpoint precision evaluation
In Table 2 the groups are compared in terms of the precision
measures and the ventilation values for normo-, hypo- and
hyperventilation. No signi®cant difference was found
between the groups for these steady-state condition results.
Measures of setpoint precision, calculated for the model-
based control group only, con®rm the stable performance of
the model-based controller.
Dynamic performance
The following 1 vol% (7 mm Hg) steps in FE¢CO2 of the
model-based control group were compared with the data
from the fuzzy-logic control group: (i) 15 downward steps
from normo- to hyperventilation (from 4.5% to 3.5%) or
from hypo- to normoventilation (from 5.5% to 4.5%); (ii) 14
upward steps from normo- to hypoventilation (from 4.5% to
5.5%) or from hyper- to normoventilation (from 3.5% to
4.5%). The rise time in the model-based group was lower
than in the fuzzy-logic group (Table 3, P<0.05). No
difference was found in the overshoot of the controllers.
The results in Table 4 show the dynamic response for the
2 vol% step changes in the model-based group. Approach to
an increased setpoint is signi®cantly slower and generates a
signi®cantly larger overshoot compared with a decrease of
setpoint (P<0.05).
Response to artefacts of the model-based controller (model-
based group only)
Short intervals of invalid FE¢CO2 measurements are seen in
Figure 2 as decreases in the FE¢CO2 curve. One event is
shown in more detail in Figure 3 when the ventilation
system was disconnected to ventilate the patient manually.
As no valid measure of FE¢CO2 was provided by the
ventilation system, the controller switched to the (calcu-
Table 1 Patient characteristics for model-based control and fuzzy-logic
control groups. Data are mean (range)
Fuzzy-logic group Model-based group
(n=30) (n=15)
Sex (F/M) 10/20 11/4
Age (yr) 47 (12±84) 38 (20±59)
Weight (kg) 67 (41±93) 66 (54±87)
Height (cm) 168.5 (153±192) 167 (156±188)
Operation type N/A 3 orthopaedic
5 breast surgery
2 laparoscopic procedures
2 back surgery
2 abdominal plastic surgery
1 leg muscle reconstruction
Fig 2 Example traces with artefacts during model-based control with FE¢CO2 reference (dashed) and actual FE¢CO2 measurement solid (top), tidal
volume (VT) (mid) and respiratory frequency f (bottom). A limb tourniquet is released at 280 min. To eliminate the accumulated carbon dioxide, the
automatic feedback controller reacted by temporarily increasing the respiratory frequency and tidal volume. The decreases in the measured FE¢CO2
curve show periods of invalid measurement which did not in¯uence the controller behaviour (see Figure 3).
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lated) predicted value of FE¢CO2, thus maintaining MV.
When the system was reconnected, the controller switched
to the measured FE¢CO2, and reacted by increasing MV in
response to an increased FE¢CO2.
The reaction of the controller after an abrupt increase in
carbon dioxide was seen after the release of a pneumatic
limb tourniquet when carbon dioxide had to be eliminated
with increased ventilation. This was rapidly obtained by the
controller by temporarily increasing f and VT (Fig. 2).
When the carbon dioxide absorbent was exhausted
towards the end of the operation, carbon dioxide accumu-
lated in the breathing system and was re-breathed by the
patient. The controller reacted by increasing MV to
maintain the target setpoint (Fig. 4).
Another example of fast reaction to an incident was
observed when the cuff of a tracheal tube leaked. The
measured FE¢CO2 dropped rapidly and the controller reduced
MV, triggering the low MV alarms of the monitor. The tube
was replaced and no harm occurred to the patient.
The effect of a pulmonary embolism was simulated. The
pulmonary shunt of the model was suddenly increased,
thereby reducing the pulmonary ¯ow and in consequence
alveolar perfusion. The control system reacted by consid-
erably decreasing MV in order to maintain FE¢CO2at the
preset level.
The potentially harmful consequences of the latter two
incidents are discussed below.
Discussion
The clinical validation of a newly developed model-based
controller for mechanical ventilation is presented. FE¢CO2 is
used as the controlled variable to adjust the ventilation
parameters. When used with ASA I±II patients, the control
system showed excellent performance and robustness in
response to artefacts. The new controller was compared
with a fuzzy-logic control system.2 In this previous study,
each patient was ventilated under either human or fuzzy-
logic control; automatic control performed as well as human
control.
Patients were satisfactorily ventilated with either control
algorithm (model-based or fuzzy-logic) and no difference
was found in the setpoint precision. The model-based
system responds signi®cantly faster to setpoint changes
(P<0.05). The SD of the rise time was less in the model-
based group (P<0.05), indicating a more consistent
behaviour with step changes. This could be useful when
rapid changes in ventilation are needed such as when carbon
dioxide partial pressure increases after limb tourniquet
Table 2 Comparison of the setpoint precision and measured ventilation values of fuzzy-logic control (FLC) vs model-based control (MBC) for normo-, hypo-
and hyperventilation. Setpoint precision is shown as mean deviation (MD) of the setpoint (MD=mean eFE¢CO2) to measure bias of the control and the SD of
eFE¢CO2 (MDS) as a measure of the stability and range of deviation of the control. For the model-based group the additional measures mean absolute deviation
(MAD), median absolute performance error (MDAPE), median performance error (MDPE), wobble and divergence were calculated. Ventilation patterns at
hypo-, normo- and hyperventilation setpoints for all patients are in steady state. f, respiratory frequency, VT/BW, tidal volume per kg body weight; MV/BW,
minute volume per kg body weight; Ppeak, peak airway pressure. All data are mean (SD)
Normoventilation (4.5% or 35 mm Hg) Hypoventilation (5.5% or 42 mm Hg) Hyperventilation (3.5% or 28 mm Hg)
FLC (n=30) MBC (n=15) FLC (n=30) MBC (n=15) FLC (n=30) MBC (n=15)
MD (vol%) ±0.01 (0.05) 0.00 (0.00) 0.00 (0.05) ±0.02 (0.00) ± 0.03 (0.00)
MDS (vol%) 0.09 (0.04) 0.07 (0.00) 0.11 (0.05) 0.12 (0.03) ± 0.09 (0.01)
MAD (vol%) ± 0.03 (0.00) ± 0.06 (0.02) ± 0.04 (0.00)
MDAPE (%) ± 0.0 (0.0) ± 0.0 (0.0) ± 0.0 (0.0)
MDPE (%) ± 0.0 (0.0) ± 0.0 (0.0) ± 0.0 (0.0)
Wobble (%) ± 0.0 (0.0) ± 0.0 (0.0) ± 0.0 (0.0)
Divergence (% h±1) ± 0.0 (0.1) ± 0.1 (0.4) ± 0.0 (0.4)
Mean f (min±1) 10.1 (1.2) 9.4 (1.2) 8.5 (0.9) 7.7 (1.0) ± 11.5 (1.0)
Mean VT/BW (ml kg
±1) 10.19 (1.05) 9.74 (0.59) 8.14 (1.00) 9.10 (0.73) ± 10.82 (0.74)
Mean MV/BW (ml min±1 kg±1) 103.3 (20.1) 91.8 (14.1) 69.9 (15.1) 70.6 (11.5) ± 124.2 (15.1)
Mean Ppeak (kPa) 2.10 (0.32) 1.69 (0.30) 1.72 (0.22) 1.55 (0.30) ± 1.94 (0.26)
Table 3 Dynamic response (rise time, time required to move from 10% to
90% of steady state of the desired change) and overshoot for upward and
downward setpoint changes (1 vol% or 7 mm Hg difference). Data are mean
(SD). *Signi®cant difference between groups (P<0.05); ²signi®cant
differences between increase and decrease of setpoint (P<0.05)
Fuzzy-logic group Model-based group
1 vol% increase of setpoint n=30 n=14
Rise time (s) 313 (90)* 144 (17.3)*²
Overshoot (vol%) 0.26 (0.22) 0.18 (0.12)
1 vol% decrease of setpoint n=29 n=15
Rise time (s) 355 (127)* 177.1 (35.7)*²
Overshoot (vol%) 0.15 (0.16) 0.14 (0.00)
Table 4 Dynamic response of the model-based controller for setpoint
changes of 2 vol% or 14 mm Hg (rise time and overshoot), model-based
group only. Data are mean (SD). *Signi®cant difference between increase and
decrease of setpoint (P<0.001)
2 vol% increase 2 vol% decrease
(n=16) (n=15)
Rise time (s) 311 (85)* 215 (18)*
Overshoot (%) 0.39 (0.15)* 0.19 (0.07)*
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release or if ventilation has to be adapted to prevent or treat
cerebral oedema.10
Additional measures of setpoint precision and dynamic
behaviour were calculated for the model-based group.
Because of the very small control bias (MD), the MAD
indicator of inaccuracy showed a direct correlation to the SD
of eFE¢CO2 (MDS), con®rming stability of control. However,
the measures de®ned by Varvel and colleagues5 and used by
others7 to estimate control quality proved to be quite
insensitive to the control deviations. Except for the very
small divergence values, all other values were zero. The use
of median values reduces sensitivity (e.g. if the controller
would maintain an exact setpoint for more than half of the
time, the indicators would be zero without showing what
Fig 4 Reaction to exhaustion of the carbon dioxide absorbent. The minute volume was increased by the controller in order to eliminate the carbon
dioxide that accumulated in the breathing system, thereby maintaining the desired setpoint of FE¢CO2 (reference FE¢CO2= 4.5%).
Fig 3 From 242.3 to 243.4 min of the trial shown in Figure 2, the ventilation system was disconnected and the patient was ventilated manually. The
controller detected artefact measurements and switched to the (calculated) predicted FE¢CO2 as input signal, thus maintaining constant ventilation
values until the ventilation system was reconnected and accumulated carbon dioxide was washed out with increased minute volume (MV).
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happened the rest of the time). In summary all these
measures indicated that the controller could regulate FE¢CO2
appropriately.
We found that the rise time for the model-based controller
was signi®cantly less for an increase than for a decrease for
the 1 vol% steps but longer for the 2 vol% steps. This was
caused by two different constraints of the controller: (i) MV
was allowed to change by only 10% from one control cycle
to the next. Increasing FE¢CO2 means decreasing MV, in
which case the actuator was reacting faster because of the
10% constraint; (ii) for the large increase the minimal MV
(2.1±2.6 litre min±1 depending on body weight) was
imposed before the 5.5% FE¢CO2 was achieved, therefore
dominating the rise time.
Bickford11 described the ®rst example of the application
of closed-loop systems in anaesthesia in 1950, in animals
and in man. Automatic control of FE¢CO2 was suggested as
early as 1974, and subsequent research showed that this
could be done.12 13 Different methods of feedback control
have been developed and implemented to improve the
control of anaesthesia, relieve physicians from routine
activities and increase safety.7 8 14±16 Several attempts have
been undertaken to automate mechanical ventilation.
Laubscher and colleagues17 described a PI-based controller
(controller with an output proportional (P) to the difference
between input value and setpoint, and to the (I) integration
of this difference over a certain time). Special selection
algorithms were used to maintain target alveolar ventilation
by selecting f and VT as close to physiological needs as
possible. This allowed ventilation to be adjusted according
to the state of health of the patient. In this case, continuous
measurements and analysis of expired carbon dioxide,
airway pressure and airway ¯ow were required.
The fuzzy-logic controller described by SchaÈublin and
colleagues2 had a satisfactory steady-state performance.
However, its structure, based on 29 interacting linguistic
rules, was very complex and hindered optimization and
artefact handling. The present model-based controller
performed well and also had a straightforward design
based on mathematical models, which could facilitate future
approval by authorities and/or of®cial bodies. The model-
based controller is `familiar' with the behaviour of the
process that it is adjusting; a priori information about the
natural process not available to model-independent control-
ler types such as fuzzy-logic can be used to improve
dynamic performance. We have shown this was indeed the
case. Furthermore, with a suf®ciently general model, the
controller can handle different ventilation regimens.
However, automatic controllers of mechanical ventilation
cannot directly recognize dead-space ventilation, for
example in the case of pulmonary embolism. With
decreasing FE¢CO2 because of increased dead-space venti-
lation, the controller would react by reducing the venti-
lation, thereby keeping FE¢CO2 as close to setpoint as
possible and this would increase arterial carbon dioxide
partial pressure. This also occurred during a trial when the
tube cuff leaked, which resulted in a reduced effective VT
and reduced alveolar ventilation. With pulmonary embo-
lism, the controller would react to the decrease of FE¢CO2
with a reduced MV, as was veri®ed in a simulation
environment. The detection of increased dead-space venti-
lation and/or circulatory compromise, leading to decreased
carbon dioxide return, is therefore possible when monitor-
ing MV. However, we consider an MV alarm to be less
dependable in a clinical setting than an FE¢CO2 alarm,
because it depends on the size of the patient. To increase
safety, we suggest that the controller should detect and
alarm if a sudden or unexplained decrease in MV occurs in
relation to patient features such as weight, height and sex. In
an alarm situation, the controller could be switched to the
(calculated) predicted value of FE¢CO2, thus maintaining MV
according to standard patterns until the anaesthetist resolves
the situation and clears the alarm. The controller could also
process the continuous carbon dioxide fraction and ¯ow
measurement, calculate anatomical dead space and signal
changes.
Automated control in anaesthesia is increasingly studied
for various input and output measurements. Because our
model-based controller can maintain adequate control
despite various measurement artefacts, it could serve as an
example for development of robust (artefact-tolerant)
controllers. Once robust control is routinely established in
anaesthesia, the simultaneous use of automatic controllers
of different systems (e.g. mean arterial pressure, bispectral
index, neuromuscular relaxation, ventilation) could consid-
erably relieve the anaesthetist from routine control work,
allow better understanding of the interactions between the
various control loops and should improve patient care. This
could open new perspectives for both research and clinical
use.
Both the fuzzy-logic and the model-based controller can
maintain a chosen setpoint with high precision. The
dynamic performance of the model-based controller was
better. The responses to several artefacts showed that the
model-based control is robust. This controller seems to meet
the requirements for routine clinical application.
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